Center-Authored Papers

Filters: Author is Gail, Mitchell H  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
Wacholder S, Hartge P, Prentice RL, Garcia-Closas M, Feigelson HS, Diver RW, Thun MJ, Cox DG, Hankinson SE, Kraft P et al..  2010.  Performance of common genetic variants in breast-cancer risk models.. The New England journal of medicine. 362(11):986-93. Abstract
P
Park J-H, Wacholder S, Gail MH, Peters U, Jacobs KB, Chanock SJ, Chatterjee N.  2010.  Estimation of effect size distribution from genome-wide association studies and implications for future discoveries.. Nature genetics. 42(7):570-5. Abstract
M
Matsuno RK, Costantino JP, Ziegler RG, Anderson GL, Li H, Pee D, Gail MH.  2011.  Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women.. Journal of the National Cancer Institute. 103(12):951-61. Abstract
Maas P, Barrdahl M, Joshi AD, Auer PL, Gaudet MM, Milne RL, Schumacher FR, Anderson WF, Check D, Chattopadhyay S et al..  2016.  Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.. JAMA oncology. Abstract
G
Greene MH, Feng Z, Gail MH.  2008.  The importance of test positive predictive value in ovarian cancer screening.. Clinical cancer research : an official journal of the American Association for Cancer Research. 14(22):7574;authorreply7577-9.
George SM, Irwin ML, Smith AW, Neuhouser ML, Reedy J, McTiernan A, Alfano CM, Bernstein L, Ulrich CM, Baumgartner KB et al..  2011.  Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer.. Cancer causes & control : CCC. 22(4):589-98. Abstract
George SM, Neuhouser ML, Mayne ST, Irwin ML, Albanes D, Gail MH, Alfano CM, Bernstein L, McTiernan A, Reedy J et al..  2010.  Postdiagnosis diet quality is inversely related to a biomarker of inflammation among breast cancer survivors.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19(9):2220-8. Abstract
F
Freedman AN, Yu B, Gail MH, Costantino JP, Graubard BI, Vogel VG, Anderson GL, McCaskill-Stevens W.  2011.  Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(17):2327-33. Abstract
B
Banegas MP, Gail MH, Lacroix A, Thompson B, Martinez ME, Wactawski-Wende J, John EM, Hubbell AF, Yasmeen S, Katki HA.  2012.  Evaluating breast cancer risk projections for Hispanic women.. Breast cancer research and treatment. 132(1):347-353. Abstract